| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/17/2007 | US20070112034 2-(benzimidazol-1-yl)-acetamide bisaryl derivatives |
| 05/17/2007 | US20070112003 3-(3-Amino-4-chloro-phenyl)-5-(3-chlorothiophen-2-yl)-[1,2,4]-oxadiazole; anticancer agents; coadministering with other chemotherapeutics or radiotherapy |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070112001 Treatment of thrombotic disorders, such as arterial and venous thrombosis, peripheral arterial occlusive disease, angina pectoris, myocardial infarction; (2S,4S)-4-[(5-chloro-thiophene-2-carbonyl)-amino]2-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 05/17/2007 | US20070112000 Chemical compounds |
| 05/17/2007 | US20070111999 P-38 kinase inhibitors |
| 05/17/2007 | US20070111998 Novel heterocyclic compounds as pSTAT3/IL-6 inhibitors |
| 05/17/2007 | US20070111992 Cathepsin K and cathepsin S dependent disorders such as osteoporosis, atherosclerosis, inflammation and immune disorders such as rheumatoid arthritis and chronic pain; e.g. 4-(piperazin-1-yl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile |
| 05/17/2007 | US20070111991 10,11-Dihydro-dibenzo[b,f]oxepine-10-carboxylic acid [(1S*,2S*,4R*)-4-butylcarbamoyl-2-hydroxy-1-(3-hydroxy-benzyl)-pentyl]-amide; treatment of neurological and vascular disorders related to beta-amyloid generation and/or aggregation |
| 05/17/2007 | US20070111982 Calcitonin Gene-Related Peptide, CGRP; treatment of migraine and cluster headache; 2,5-dioxo-3',4'-dihydro-spiro(imidazolidine-4,2'(1'H)-naphthalene)-6'-carboxamides |
| 05/16/2007 | EP1785418A1 Pyrazole derivative |
| 05/16/2007 | EP1785415A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 05/16/2007 | EP1784401A1 Urea derivatives as calcium channel blockers |
| 05/16/2007 | EP1784400A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/16/2007 | EP1784392A2 Pyrimidine derivatives |
| 05/16/2007 | EP1588145A4 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 05/16/2007 | EP1465638B1 Phosphate transport inhibitors |
| 05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/16/2007 | CN1964970A Iap的抑制剂 Iap inhibitors |
| 05/16/2007 | CN1964956A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 05/16/2007 | CN1964946A 2-propylene-1-ones as hsp70 inducer |
| 05/16/2007 | CN1964944A Indole derivatives as antiviral agents |
| 05/16/2007 | CN1964718A Leptomycin compounds |
| 05/16/2007 | CN1315813C 2-amino-4h-3,1-benzoxazin-4-one derivatives for the treatment of obesity |
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217819 Immobilization of taxane; anticancer, antitumor agents |
| 05/15/2007 | US7217726 Oxazolidinon-3-ylphenyl -piperazine, -imidazolidine, and -diazepine derivatives, e.g., S)-N-[3-[3-Fluoro-4-[4-(5-nitrofuran-2-ylthiocarbonyl)piperazin-1-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]thioacetamide; treating bacterial infections, particularly those that are antibiotic resistant |
| 05/15/2007 | US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217713 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/15/2007 | US7217710 Pyrazolo-pyrimidine compound; anticancer agents |
| 05/15/2007 | US7217709 Tetracyclic benzamide derivatives and methods of use thereof |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 05/15/2007 | CA2236293C Intermediates for the hemisynthesis of taxanes and processes for their preparation |
| 05/10/2007 | WO2007053819A2 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| 05/10/2007 | WO2007053499A2 Compounds useful as antagonists of ccr2 |
| 05/10/2007 | WO2007053498A1 Compounds useful as antagonists of ccr2 |
| 05/10/2007 | WO2007053436A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 05/10/2007 | WO2007053094A1 CHROMAN COMPOUNDS AS 5 -HTlB ANTAGONISTS |
| 05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
| 05/10/2007 | WO2007052794A1 o-SUBSTITUTED ANILINE DERIVATIVE AND ANTIOXIDANT DRUG |
| 05/10/2007 | WO2007052615A1 Pyridine derivative substituted by heterocycle and fungicide containing the same |
| 05/10/2007 | WO2007052123A2 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 05/10/2007 | WO2007051846A1 Tricyclo substituted amides |
| 05/10/2007 | WO2007051845A1 Tricyclo substituted amides |
| 05/10/2007 | WO2007051532A1 Phenylenebisoxazolidine derivatives and their use as anticoagulants |
| 05/10/2007 | WO2007025897A3 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 05/10/2007 | WO2006105081A3 Pharmacokinetically improved compounds |
| 05/10/2007 | US20070106075 Triazine based photoactive compound containing oxime ester |
| 05/10/2007 | US20070105944 Taxane metabolites |
| 05/10/2007 | US20070105922 High affinity and selectivity for GABA A alpha 5 receptor binding sites ; cognitive enhancer; Alzheimer's disease; benzofuran-2-yl-[3-(4-bromo-phenyl)-5-methyl-isoxazol-4-yl]-methanone |
| 05/10/2007 | US20070105913 Alkynyl aryl carboxamides |
| 05/10/2007 | US20070105908 Thiazolimine compound and oxazolimine compound |
| 05/10/2007 | US20070105906 N-(1-{3-[(R)-2-[3-(phenylsulphonylamino)-phenyl]-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-indol-5-yl)-2-cyano-acetamide, used for treating non-insulin dependent diabetes, obesity or overactive bladder |
| 05/10/2007 | US20070105905 Novel macrocycles for the treatment of cancer |
| 05/10/2007 | US20070105904 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; inhibiting fungal GPI biosynthesis thereby inhibiting expression of cell wall proteins and blocking cell wall assembly while preventing the fungus from attaching to cells |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105893 e.g. 2-[(4-Ethoxyphenyl)methyl]-1-(3-methylbutyl)-N,N-bis(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide; agonists at cannabinoid 2 receptor; analgesic agent, anticarcinogenic agent, neurodegenerative diseases; multiple sclerosis, Parkinson's disease, Huntington's chorea or Alzheimer's disease. |
| 05/10/2007 | US20070105892 Amidino compounds as cysteine protease inhibitors |
| 05/10/2007 | US20070105872 N-[6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl]-3-methylisoxazole-4-carboxamide; N-[6-amino-5-(2,3-dichloro-5-methoxyphenyl)pyrazin-2-yl]-1-methyl-1H-pyrazole-5-carboxamide |
| 05/10/2007 | US20070105868 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 05/10/2007 | US20070105865 Substituted bicyclic quinazolin-4-ylamine derivatives |
| 05/10/2007 | US20070105862 Heat-shock protein binders |
| 05/10/2007 | US20070105857 Process for Making Heteroaryl Amine Intermediate Compounds |
| 05/10/2007 | US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/10/2007 | US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/10/2007 | US20070105853 2-'4-(Hydroxymethyl-phenylamino)-piperidine-1-yl!-n-(9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 05/10/2007 | US20070105847 1,3-Dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 05/10/2007 | US20070105846 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 05/10/2007 | US20070105836 Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 05/10/2007 | US20070105834 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide |
| 05/10/2007 | US20070105833 including cystic fibrosis transmembrane conductance regulator ("CFTR"), such as 4-amido-pyrimidine compounds and derivatives, used for treating genetic disorders; respiratory system disorders |
| 05/10/2007 | CA2628486A1 Tricyclo substituted amides |
| 05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
| 05/10/2007 | CA2627759A1 Phenylenebisoxazolidine derivatives and their use as anticoagulants |
| 05/10/2007 | CA2626475A1 Tricyclo substituted amides |
| 05/09/2007 | EP1781648A2 1,3,4-oxadiazol-2-ones as ppar delta modulators |
| 05/09/2007 | EP1781645A1 Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 05/09/2007 | EP1781644A1 Macrocyclic beta-secretase inhibitors |
| 05/09/2007 | EP1781643A1 Oxindole oxazolidinones as antibacterial agents |
| 05/09/2007 | EP1781642A1 Oxazolidinones containing oxindoles as antibacterial agents |
| 05/09/2007 | EP1781640A1 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors |
| 05/09/2007 | EP1781635A2 Potassium channel inhibitors |
| 05/09/2007 | EP1781633A1 Novel antidiabetic compounds |
| 05/09/2007 | EP1781620A1 Novel beta agonists, method for producing the same and their use as drugs |
| 05/09/2007 | EP1781606A2 Azetidine derivatives as ccr-3 receptor antagonists |
| 05/09/2007 | EP1597238B1 Hiv replication inhibiting pyrimidines and triazines |
| 05/09/2007 | EP1572667B1 Cathepsin cysteine protease inhibitors and their use in the treatment of inflammation and immune disorders |
| 05/09/2007 | EP1272477B1 Pyrimidine compounds |
| 05/09/2007 | EP1238970B9 Cycloamine ccr5 receptor antagonists |
| 05/09/2007 | EP1183245B1 Selective npy (y5) antagonists |
| 05/09/2007 | CN1960990A Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 05/09/2007 | CN1960985A Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 05/09/2007 | CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 05/09/2007 | CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists |
| 05/09/2007 | CN1960969A Histamine H3 receptor agents, preparation method and therapeutic uses thereof |
| 05/09/2007 | CN1960726A Composition comprising a jnk inhibitor and cyclosporin |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |